Home/Filings/4/0001415889-23-014586
4//SEC Filing

Murray Christopher K. 4

Accession 0001415889-23-014586

CIK 0001597264other

Filed

Oct 29, 8:00 PM ET

Accepted

Oct 30, 2:01 PM ET

Size

12.4 KB

Accession

0001415889-23-014586

Insider Transaction Report

Form 4
Period: 2023-10-26
Murray Christopher K.
SVP, Technical Operations
Transactions
  • Sale

    Common Stock

    2023-10-26$56.40/sh600$33,84025,095 total
Footnotes (1)
  • [F1]Effected pursuant to a trading plan adopted on June 5, 2023 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

Issuer

Blueprint Medicines Corp

CIK 0001597264

Entity typeother

Related Parties

1
  • filerCIK 0001718648

Filing Metadata

Form type
4
Filed
Oct 29, 8:00 PM ET
Accepted
Oct 30, 2:01 PM ET
Size
12.4 KB